CYP3A4∗18B and CYP3A5∗3 polymorphisms contribute to pharmacokinetic variability of cyclosporine among healthy Chinese subjects
Xing-ru Tao, Xiu-yuan Xia, Jing Zhang, Tong Lian-ying, Wei Yan Zhang, Xin Zhou, Zhi-hong Liu, Song Hong-tao
Abstract
Xing-ru Tao, Xiu-yuan Xia, Jing Zhang, Tong Lian-ying, Wei Yan Zhang, Xin Zhou, Zhi-hong Liu, Song Hong-tao
Abstract
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: CYP3A5, CYP3A4, Pharmacokinetics, Cmax, Pharmacology, Restriction fragment length polymorphism, Medicine, Internal medicine